Technical Analysis for EW - Edwards Lifesciences Corporation

Grade Last Price % Change Price Change
grade A 244.36 -0.52% -1.28
EW closed up 2.11 percent on Friday, November 15, 2019, on 1.43 times normal volume. The bulls were able to push the stock to a new 52-week high. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical EW trend table...

Date Alert Name Type % Chg
New 52 Week Closing High Bullish -0.52%
Pocket Pivot Bullish Swing Setup -0.52%
New 52 Week High Strength -0.52%
Overbought Stochastic Strength -0.52%
Inside Day Range Contraction 1.58%
Overbought Stochastic Strength 1.58%
MACD Bullish Signal Line Cross Bullish 0.82%
New 52 Week Closing High Bullish 0.82%
New Uptrend Bullish 0.82%
New 52 Week High Strength 0.82%

Older signals for EW ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients worldwide. The company offers surgical heart valve therapy products, such as tissue heart valves and repair products, which are used to replace or repair a patient's diseased or defective heart valve; and produces pericardial and porcine valves. Its surgical heart valve therapy products include Carpentier-Edwards PERIMOUNT pericardial valve that comprise PERIMOUNT Magna Ease valves for aortic and mitral replacement; ThruPort systems that enable minimal incision valve surgery; and protection cannulae used during cardiac surgery in venous drainage, aortic perfusion, venting, and cardioplegia delivery. The company also provides transcatheter heart valves portfolio that includes technologies designed to treat heart valve disease using catheter-based approaches, as well as critical care products, such as hemodynamic monitoring systems to measure a patient's heart function in surgical and intensive care settings; Swan-Ganz line of pulmonary artery catheters and PreSep continuous venous oximetry catheters for measuring central venous oxygen saturation; VolumeView sensor-catheters; FloTrac continuous cardiac output monitoring system, a minimally invasive cardiac monitoring technology for goal-directed fluid optimization; and EV1000 clinical monitoring platform, which displays a patient's physiologic status. Its critical care products also include disposable pressure monitoring devices and closed blood sampling systems to help protect both patients and clinicians from the risk of infection; and products used to treat endolumenal occlusive disease, including balloon-tipped, catheter-based embolectomy products, surgical clips, and clamps. The company distributes its products through direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1999 and is headquartered in Irvine, California.
Medicine Medical Specialties Clinical Medicine Surgery Infection Catheters Catheter Drainage Cardiac Surgery Incision Care Products Heart Repair Products Cardiac Output Edwards Lifesciences Heart Valve Valvular Heart Disease
Is EW a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 245.95
52 Week Low 139.64
Average Volume 1,107,490
200-Day Moving Average 198.3891
50-Day Moving Average 226.746
20-Day Moving Average 234.8435
10-Day Moving Average 237.486
Average True Range 4.832
ADX 27.9
+DI 31.4263
-DI 12.0183
Chandelier Exit (Long, 3 ATRs ) 231.454
Chandelier Exit (Short, 3 ATRs ) 236.096
Upper Bollinger Band 246.533
Lower Bollinger Band 223.154
Percent B (%b) 0.96
BandWidth 9.95514
MACD Line 4.2775
MACD Signal Line 3.7342
MACD Histogram 0.5433
Fundamentals Value
Market Cap 51.87 Billion
Num Shares 211 Million
EPS 3.30
Price-to-Earnings (P/E) Ratio 74.44
Price-to-Sales 6.75
Price-to-Book 7.42
PEG Ratio 1.70
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 252.26
Resistance 3 (R3) 251.62 248.79 251.15
Resistance 2 (R2) 248.79 247.10 249.10 250.78
Resistance 1 (R1) 247.21 246.06 248.00 247.85 250.42
Pivot Point 244.38 244.38 244.77 244.69 244.38
Support 1 (S1) 242.80 242.69 243.59 243.44 240.86
Support 2 (S2) 239.97 241.65 240.28 240.50
Support 3 (S3) 238.39 239.97 240.13
Support 4 (S4) 239.03